- Pin
- 🥳 Earning Growth Points can Win an iPhone 16?
🔥 Gate Post Growth Points Summer Lucky Draw Round 1️⃣ 1️⃣ Is Live!
🎁Prize pool over $10,000! Win iPhone 16 Pro Max 512G, exclusive Gate merch, popular tokens & more!
Try your luck now 👉 https://www.gate.com/activities/pointprize?now_period=11
How to earn Growth Points fast?
1️⃣ Go to [Post], tap the icon next to your avatar to enter [Community Center]
2️⃣ Complete daily tasks like posting, commenting, liking, and chatting to earn points
New feature this round: “Fragment Exchange”! Collect fragments to redeem exclusive Gate merch!
100% chance t
- 【Gate Daily Market Digest】📊
Unlock today’s key crypto market insights at a glance!
Top Gainers⭐️ $TQ $GOCHU $VELAAI $BUBB $XPRESS
Trending Coins🔥 $ZBCN $TQ $WCT $EIGEN $MXC
#FearGreedIndex# #TopGainers#
- #Digital Asset Market Clarity Act#
US House Republicans have introduced the Digital Asset Market Clarity Act to clarify crypto regulations. The bill gives the CFTC exclusive authority over digital commodity spot markets, and crypto platforms can register with either the CFTC or SEC. Will this reshape crypto regulation? What’s your take?
#Trump Tariff Update#
A US appeals court has reinstated Trump-era tariffs during the appeal, and further tariff hikes (up to 15% for 150 days) are being considered. Could these tariffs return? How might this affect the crypto market?
#Nvidia Tops Global Marke
Bai Aotai: Signed authorization, production, supply, and commercialization protocol for BAT2306 (sukunumab) injection with Stein.
On December 16th, Jinshi Data News, the company signed an authorization license with SteinCares for the production, supply, and commercialization of the protocol, granting Stein the exclusive commercialization rights for the company's BAT2306 (Sikuchenyou monoclonal antibody) injection solution in the Brazilian and other Latin American markets. The transaction amount is up to a maximum of $8 million, including a $1.2 million down payment, a cumulative milestone payment of no more than $6.8 million, and a double-digit percentage of net sales as revenue sharing.